M&T Bank Corp Has $114.13 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

M&T Bank Corp grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 225,622 shares of the healthcare conglomerate's stock after purchasing an additional 5,032 shares during the period. M&T Bank Corp's holdings in UnitedHealth Group were worth $114,132,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. DecisionPoint Financial LLC lifted its position in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after purchasing an additional 62 shares during the last quarter. Finally, Legacy Investment Solutions LLC bought a new stake in UnitedHealth Group in the third quarter valued at about $57,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Stock Up 0.3 %

Shares of UNH traded up $1.61 during mid-day trading on Wednesday, reaching $476.22. The company's stock had a trading volume of 3,636,081 shares, compared to its average volume of 4,991,972. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market cap of $438.25 billion, a price-to-earnings ratio of 30.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The business has a fifty day moving average of $514.58 and a 200 day moving average of $554.81.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 EPS. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.